MedPath

Sperm DNA Damage to Intracytoplasmic Sperm Injection Outcome

Completed
Conditions
Infertility, Male
Registration Number
NCT03129243
Lead Sponsor
Assiut University
Brief Summary

In the current era of assisted reproductive techniques where technology can help overcome defects in sperm function, the value of semen analysis has become even more inaccurate. Initial reports of intracytoplasmic sperm injection revealed its ability to bypass the natural selection process and enable men with severely impaired semen parameters to achieve both clinical pregnancy and live birth

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
120
Inclusion Criteria
  1. Infertile male patients with abnormal semen parameters.
  2. Normal female partner aged <38 years.
Read More
Exclusion Criteria
  1. Female patients with obvious infertility factor.
  2. Male patients with azoospermia.
  3. Male patients with systemic diseases.
  4. Male patients receiving cytotoxic therapy.
  5. Male patients with genital pathology as cryptorchidism.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
clinical pregnancy rate4 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ahmed Abbas

🇪🇬

Assiut, Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath